Որոնման արդյունքները - David B. Rawlins
- Ցուցադրվում են 1 - 3 արդյունքները 3
-
1
-
2
LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial Brian Zambrowicz, J Freiman, Phil Brown, Kenny Frazier, Anne Turnage, J Bronner, D Ruff, Melanie K. Shadoan, Phillip Banks, Faika Mseeh, David B. Rawlins, Nicole C. Goodwin, Ross Mabon, Bryce A. Harrison, Alan Wilson, Arthur Sands, David R. Powell
Հրապարակվել է 2012Artigo -
3
Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma Bryce A. Harrison, Zheng Y. Almstead, Hugh A. Burgoon, Michael Gardyan, Nicole C. Goodwin, Jason Healy, Ying Liu, Ross Mabon, Brett Marinelli, Lakshman Samala, Yulian Zhang, Terry R. Stouch, N. Andrew Whitlock, Suma Gopinathan, Beth McKnight, Shuli Wang, Nita Patel, Alan Wilson, Brian D. Hamman, Dennis S. Rice, David B. Rawlins
Հրապարակվել է 2014Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Biochemistry
Chemistry
Internal medicine
Kinase
Medicine
Pharmacology
Allosteric regulation
Alternative medicine
Amide
Clinical trial
Diabetes mellitus
Dosing
Endocrinology
Enzyme
Glaucoma
Glucagon
Glycemic
Insulin
Intraocular pressure
Non-competitive inhibition
Ocular hypertension
Ophthalmology
Pathology
Placebo
Renal glucose reabsorption
Rho-associated protein kinase
Small molecule
Stereochemistry
Type 2 Diabetes Mellitus
Type 2 diabetes